122 related articles for article (PubMed ID: 17678923)
1. Natural history and clinical impact of cryoglobulins in chronic hepatitis C: 10-year prospective study of 343 patients.
Viganò M; Lampertico P; Rumi MG; Folli C; Maggioni L; Morabito A; Del Ninno E; Cicardi M; Colombo M
Gastroenterology; 2007 Sep; 133(3):835-42. PubMed ID: 17678923
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and incidence of cryoglobulins in hepatitis C virus-related chronic hepatitis patients: a prospective study.
Persico M; De Marino FA; Di Giacomo Russo G; Persico E; Morante A; Palmentieri B; Torella R
Am J Gastroenterol; 2003 Apr; 98(4):884-8. PubMed ID: 12738472
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma mansoni coinfection could have a protective effect against mixed cryoglobulinaemia in hepatitis C patients.
Abbas OM; Omar NA; Zaghla HE; Faramawi MF
Liver Int; 2009 Aug; 29(7):1065-70. PubMed ID: 19192170
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans.
Kayali Z; Tan S; Shinkunas L; Voigt M; LaBrecque DR; Stapleton JT; Brown KE; Schmidt WN
J Viral Hepat; 2007 Jan; 14(1):11-21. PubMed ID: 17212639
[TBL] [Abstract][Full Text] [Related]
6. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of cryoglobulinemia in patients with chronic HCV infection.
Liakina V; Speiciene D; Irnius A; Naraskeviciene J; Barakauskiene A; Semuchiniene T
Med Sci Monit; 2002 Jan; 8(1):CR31-6. PubMed ID: 11782678
[TBL] [Abstract][Full Text] [Related]
8. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
9. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection.
Vallat L; Benhamou Y; Gutierrez M; Ghillani P; Hercher C; Thibault V; Charlotte F; Piette JC; Poynard T; Merle-Béral H; Davi F; Cacoub P
Arthritis Rheum; 2004 Nov; 50(11):3668-78. PubMed ID: 15529359
[TBL] [Abstract][Full Text] [Related]
10. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
[TBL] [Abstract][Full Text] [Related]
11. Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels.
Hui CK; Zhang HY; Shek T; Yao H; Yueng YH; Leung KW; Lai ST; Lai JY; Leung N; Lau GK
Aliment Pharmacol Ther; 2007 Jun; 25(11):1283-92. PubMed ID: 17509096
[TBL] [Abstract][Full Text] [Related]
12. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.
Cacoub P; Poynard T; Ghillani P; Charlotte F; Olivi M; Piette JC; Opolon P
Arthritis Rheum; 1999 Oct; 42(10):2204-12. PubMed ID: 10524695
[TBL] [Abstract][Full Text] [Related]
13. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients.
Sangiovanni A; Prati GM; Fasani P; Ronchi G; Romeo R; Manini M; Del Ninno E; Morabito A; Colombo M
Hepatology; 2006 Jun; 43(6):1303-10. PubMed ID: 16729298
[TBL] [Abstract][Full Text] [Related]
14. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.
Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R
Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133
[TBL] [Abstract][Full Text] [Related]
16. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
Lemos LB; Perez RM; Lemos MM; Draibe SA; Silva IS; Silva AE; Ferraz ML
Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916
[TBL] [Abstract][Full Text] [Related]
20. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
